作者: Christophe Chassard , Gerhard Rogler , Tomas de Wouters , Christophe Lacroix
DOI:
关键词:
摘要: The present invention relates to novel compositions comprising specific consortia of living bacteria strains; the manufacturing such compositions, particularly by co-cultivation; and use in pharmaceutical applications, as treatment diseases associated with intestinal microbiota dysbiosis, infections CDI (Clostridium difficile infection) IBD (Inflammatory bowel diseases)